The Integration Conversation
The Integration Conversation
brom
7: Compass Pathways Deep Dive - Patents, Peter Thiel and the Quest for a Psychedelic Monopoly
1 hour 6 minutes Posted Mar 17, 2021 at 3:53 pm.
0:00
1:06:07
Download MP3
Show notes

๐Ÿ„ Compass Pathways is the largest psychedelic stock by market cap, and was famously backed by Paypal and Palantir Founder Peter Thiel.  In this episode I investigate Compass Pathways and answer questions like:

  • What does Compass Pathway's FDA therapy designation mean for their future?    
  • What does Peter Thiel want to do with psychedelics?     
  • What's the deal with Compass Pathways patent strategy?  Can you really patent soft furniture, dark rooms and cool music?    
  • What's Compass Pathway's beef with Dr. Bronners Soap?    
  • Who wins in the battle between Compass Pathways and Non-Profits    
  • What are the risks to Compass Pathway's business?     
  • And of course the ultimate question for investors:  is Compass Pathways a Buy?

   

๐Ÿ“บWatch on YouTube:

https://youtu.be/ha2GMoZ7s60


๐Ÿ“น Clips Channel: 

https://www.youtube.com/channel/UCDzauugr4QA5dfcwaE1rweQ


๐ŸŽ‡ Clips and other stuff on Instagram: 

https://instagram.com/bromtalks


๐Ÿฆ brom on twitter:

https://twitter.com/therealbrom


Disclaimer: This recording is not financial advice.  You should not make any investment or trading decision based on the contents of this recording.  Do not consider anything in this video to be professional advice.  Brom holds long positions in Compass Pathways as well as other psychedelic stocks.